Innovations In Clinical Neuroscience

SEP-OCT 2014

A peer-reviewed, evidence-based journal for clinicians in the field of neuroscience

Issue link: http://innovationscns.epubxp.com/i/425963

Contents of this Issue

Navigation

Page 46 of 201

[ V O L U M E 1 1 , N U M B E R 9 – 1 0 , S E P T E M B E R – O C T O B E R 2 0 1 4 ] Innovations in CLINICAL NEUROSCIENCE 47 ABSTRACT Objective: To explore the authors' predictions 1) that hopelessness would positively correlate with suicidal ideation and that impulsivity (either transient urges to self-harm or impulsive acting out) would positively correlate with suicidal behavior, and 2) that the recent or long-standing nature of the traits will have corresponding effects on reported histories of suicidal ideation and behavior. Design: Questionnaire validation trial in which each subject received every measure in counterbalanced fashion. Setting: Inpatient and outpatient psychiatric settings associated with a medium-sized medical school in the southeastern United States. Participants: Forty-five subjects presenting with varying levels of suicidal ideation and behavior completed measures providing information about their histories of suicidal ideation and behavior, recent feelings of hopelessness, feelings of general hopelessness, recent feelings of difficulty controlling urges to self- FUNDING: Janssen supported UAB for data collection and training associated with this project, but there was no funding to authors or anyone else for the writing of the manuscript. FINANCIAL DISCLOSURES: Dr. McCullumsmith has no conflicts of interest relevant to the content of this article; Dr. Williamson is an employee and stockholder in Johnson and Johnson, Janssen Scientific Affairs's parent company; Ms. May has no conflicts of interest relevant to the content of this article; Ms. Bruer has no conflicts of interest relevant to the content of this article; Dr. Sheehan is the author and copyright holder of the Sheehan-Suicide Tracking Scale (S-STS), the Sheehan- Suicidality Tracking Scale Clinically Meaningful Change Measure Version (S- STS CMCM), the Pediatric versions of the S-STS, the Sheehan Disability Scale (SDS), and the Suicidality Modifiers Scale, is a co- author of the Suicide Plan Tracking Scale (SPTS), and owns stock in Medical Outcomes Systems, which has computerized the S-STS; Dr. Alphs is employed by Janssen Scientific Affairs, Titusville, New Jersey, and is a stockholder of Johnson & Johnson. ADDRESS CORRESPONDENCE TO: Cheryl McCullumsmith, MD PhD, 260 Stetson Street, Suite 3200 Cincinnati, OH 45219; E-mail: cheryl.mccullumsmith@uc.edu KEY WORDS: Suicidality, assessment [ O R I G I N A L R E S E A R C H ] Simple Measures of Hopelessness and Impulsivity are Associated with Acute Suicidal Ideation and Attempts in Patients in Psychiatric Crisis by CHERYL B. MCCULLUMSMITH, MD, PhD; DAVID J. WILLIAMSON, PhD; ROBERTA S. MAY, MA ; EMILY H. BRUER, M.Ed; DAVID V. SHEEHAN, MD, MBA; and LARRY D. ALPHS, MD, PhD Dr. McCullumsmith is with the University of Cincinnati Department of Psychiatry and Behavioral Neuroscience, Cincinnati, Ohio; Dr. Williamson is with the University of South Alabama College of Medicine, Departments of Psychiatry and Neurology, Birmingham, Alabama, and Janssen Medical Affairs, LLC, Titusville, New Jersey; Ms. May is with the University of Alabama, Birmingham, Alabama; Ms Bruer is with the University of Alabama, Department of Psychiatry and Behavioral Neurobiology, Birmingham, Alabama; Dr. Sheehan is Distinguished University Health Professor Emeritus, University of South Florida College of Medicine, Tampa, Florida; and Dr. Alphs is with Janssen Medical Affairs, LLC, Titusville, New Jersey. Innov Clin Neurosci. 2014;11(9–10):47–53

Articles in this issue

Links on this page

Archives of this issue

view archives of Innovations In Clinical Neuroscience - SEP-OCT 2014